VAGUS NERVE AND ALS

Neuronium
06/01/2024
last update1 June 2024

VAGUS NERVE AND ALS :

Vagus nerve stimulation (VNS) has been explored as a potential therapeutic approach for amyotrophic lateral sclerosis (ALS), a progressive neurodegenerative disease affecting motor neurons. Here are the key points regarding VNS in ALS:

– Preclinical studies in animal models of ALS have shown that VNS can delay disease progression, improve motor function, and extend survival.[1][2]

– The proposed mechanisms involve modulation of neuroinflammation, enhancement of neurotrophic factors, and preservation of motor neurons through the vagus nerve’s connections with the brainstem and spinal cord.[1][2]

– A pilot clinical study evaluated the safety and tolerability of VNS in 17 ALS patients over a period of 6 months.[3] The treatment was well-tolerated, and some patients showed slower disease progression compared to historical controls

– Despite the negative results in some studies , some researchers argue that VNS may still hold promise for ALS if optimized stimulation parameters and patient selection criteria are employed.[
. Further research is needed to determine the optimal stimulation protocols and identify potential subgroups of ALS patients who may benefit from this neuromodulatory approach.[1][2][3][4][5]

Sources